Correction: Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.(Journal of Biological Chemistry(2014) 289 (15788–15797)Doi: 10.1074/jbc.M114.559344);Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation

Journal of Biological Chemistry

Volumn 289, Issue 22, 2014, Pages 15788-15797

  Rowley, Sean M ^a   Kuriakose, Teneema ^a   Dockery, Lee M ^a   Tran Ngyuen, Thi ^a   Gingerich, Aaron D ^a   Wei, Lai ^b   Watford, Wendy T ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

ACTIVATED MACROPHAGES; AUTOIMMUNE DISORDER; CELLULAR MIGRATION; CHEMOKINE RECEPTOR EXPRESSION; CHEMOKINES; INFLAMMATORY CONDITIONS; LOCAL ACCUMULATIONS; TUMOR PROGRESSIONS;

MACROPHAGES;

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; THIOGLYCOLIC ACID; TUMOR PROGRESSION LOCUS 2 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW DERIVED MACROPHAGE; CELL STIMULATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; MOUSE MODEL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AUTOIMMUNITY; CHEMOKINES; INFLAMMATION; LIPOPOLYSACCHARIDE (LPS); MACROPHAGES;

ACUTE DISEASE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL MOVEMENT; CHEMOKINES; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PROTO-ONCOGENE PROTEINS; RECEPTORS, CCR1; RECEPTORS, CCR2; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 84901721435     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC120.014105     Document Type: Erratum

References (63)

1. Tak, P. P., Smeets, T. J., Daha, M. R., Kluin, P. M., Meijers, K. A., Brand, R., Meinders, A. E., and Breedveld, F. C. (1997) Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40, 217-225
2. Davignon, J. L., Hayder, M., Baron, M., Boyer, J. F., Constantin, A., Apparailly, F., Poupot, R., and Cantagrel A. (2013) Targeting monocytes/ macrophages in the treatment of rheumatoid arthritis. Rheumatology 52, 590-598
3. Barnett, M. H., and Prineas, J. W. (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55, 458-468
4. Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., and Dijkstra, C. D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033
5. Trebst, C., Sørensen, T. L., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., and Ransohoff, R. M. (2001) CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159, 1701-1710
6. Clark, R. A., and Kupper, T. S. (2006) Misbehaving macrophages in the pathogenesis of psoriasis. J. Clin. Invest. 116, 2084-2087
7. Wang, H., Peters, T., Kess, D., Sindrilaru, A., Oreshkova, T., Van Rooijen, N., Stratis, A., Renkl, A. C., Sunderkötter, C., Wlaschek, M., Haase, I., and Scharffetter-Kochanek, K. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116, 2105-2114
8. Stratis, A., Pasparakis, M., Rupec, R. A., Markur, D., Hartmann, K., Scharffetter- Kochanek, K., Peters, T., van Rooijen, N., Krieg, T., and Haase, I. (2006) Pathogenic role for skin macrophages in a mouse model of keratinocyte- induced psoriasis-like skin inflammation. J. Clin. Invest. 116, 2094-2104
9. Olson, T. S., and Ley, K. (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7-R28
10. García-Ramallo, E., Marques, T., Prats, N., Beleta, J., Kunkel, S. L., and Godessart, N. (2002) Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J. Immunol. 169, 6467-6473
11. Khan, I. A., Murphy, P. M., Casciotti, L., Schwartzman, J. D., Collins, J., Gao J.-L., and Yeaman, G. R. (2001) Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. J. Immunol. 166, 1930-1937
12. Domachowske, J. B., Bonville, C. A., Gao, J. L., Murphy, P. M., Easton, A. J., and Rosenberg, H. F. (2000) The chemokine macrophage-inflammatory protein-1α and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J. Immunol. 165, 2677-2682
13. Rodriguez-Sosa, M., Rosas, L. E., Terrazas, L. I., Lu, B., Gerard, C., and Satoskar, A. R. (2003) CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection. Immunol. Cell Biol. 81, 114-120
14. Seki, E., De Minicis, S., Gwak, G. Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., and Schwabe, R. F. (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J. Clin. Invest. 119, 1858-1870
15. Kurihara, T., Warr, G., Loy, J., and Bravo, R. (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186, 1757-1762
16. Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Jr., Broxmeyer, H. E., and Charo, I. F. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561
17. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., and Berger, E. A. (1996) CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958
18. Jones, K. L., Maguire, J. J., and Davenport, A. P. (2011) Chemokine receptor CCR5: from AIDS to atherosclerosis. Br. J. Pharmacol. 162, 1453-1469
19. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., Lira, S. A., Habenicht, A. J., and Randolph, G. J. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194
20. Gautier, E. L., Jakubzick, C., and Randolph, G. J. (2009) Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1412-1418
21. Ruggiero, T., Trabucchi, M., De Santa, F., Zupo, S., Harfe, B. D., McManus, M. T., Rosenfeld, M. G., Briata, P., and Gherzi, R. (2009) LPS induces KH-type splicing regulatory protein-dependent processing of microRNA- 155 precursors in macrophages. FASEB J. 23, 2898-2908
22. Archer, K. A., and Roy, C. R. (2006) MyD88-dependent responses involving Toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect. Immun. 74, 3325-3333
23. Parker, L. C., Whyte, M. K., Vogel, S. N., Dower, S. K., Sabroe, I. (2004) Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J. Immunol. 172, 4977-4986
24. Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J. H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G., Tsichlis, P. N. (2000) TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083
25. Banerjee, A., Gugasyan, R., McMahon, M., and Gerondakis, S. (2006) Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 103, 3274-3279
26. Mielke, L. A., Elkins, K. L., Wei, L., Starr, R., Tsichlis, P. N., O'Shea, J. J., and Watford, W. T. (2009) Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1β production. J. Immunol. 183, 7984-7993
27. George, D., and Salmeron, A. (2009) Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease. Curr. Top. Med. Chem. 9, 611-622
28. Hall, J. P., Kurdi, Y., Hsu, S., Cuozzo, J., Liu, J., Telliez, J.-B., Seidl, K. J., Winkler, A., Hu, Y., Green, N., Askew, G. R., Tam, S., Clark, J. D., and Lin, L.-L. (2007) Pharmacologic inhibition of Tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood. J. Biol. Chem. 282, 33295-33304
29. Cusack, K., Allen, H., Bischoff, A., Clabbers, A., Dixon, R., Fix-Stenzel, S., Friedman, M., Gaumont, Y., George, D., Gordon, T., Grongsaard, P., Janssen, B., Jia, Y., Moskey, M., Quinn, C., Salmeron, A., Thomas, C., Wallace, G., Wishart, N., and Yu, Z. (2009) Identification of a selective thieno[2,3- c]pyridine inhibitor of COT kinase and TNF-α production. Bioorg. Med. Chem. Lett. 19, 1722-1725
30. Green, N., Hu, Y., Janz, K., Li, H. Q., Kaila, N., Guler, S., Thomason, J., Joseph-McCarthy, D., Tam, S. Y., Hotchandani, R., Wu, J., Huang, A., Wang, Q., Leung, L., Pelker, J., Marusic, S., Hsu, S., Telliez, J. B., Hall, J. P., Cuozzo, J. W., and Lin, L. L. (2007) Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factorα (TNF-α) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4- anilino-6- aminoquinoline-3-carbonitriles. J. Med. Chem. 50, 4728-4745
31. Soria-Castro, I., Krzyzanowska, A., Pelaéz, M. L., Regadera, J., Ferrer, G., Montoliu, L., Rodríguez-Ramos, R., Fernández, M., and Alemany, S. (2010) Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation. J. Biol. Chem. 285, 33805-33815
32. Bandow, K., Kusuyama, J., Shamoto, M., Kakimoto, K., Ohnishi, T., and Matsuguchi, T. (2012) LPS-induced chemokine expression in both MyD88-dependent and -independent manners is regulated by Cot/Tpl2- ERK axis in macrophages. FEBS Lett. 586, 1540-1546
33. Kaiser, F., Cook, D., Papoutsopoulou, S., Rajsbaum, R., Wu, X., Yang, H. T., Grant, S., Ricciardi-Castagnoli, P., Tsichlis, P. N., Ley, S. C., and O'Garra, A. (2009) Tpl-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863-1871
34. Sugimoto, K., Ohata, M., Miyoshi, J., Ishizaki, H., Tsuboi, N., Masuda, A., Yoshikai, Y., Takamoto, M., Sugane, K., Matsuo, S., Shimada, Y., and Matsuguchi, T. (2004) A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J. Clin. Invest. 114, 857-866
35. Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N., Luini, W., Polentarutti, N., Sozzani, S., and Mantovani, A. (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185, 969-974
36. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., and Beutler, B. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748
37. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., and Akira, S. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643
38. López-Pelaéz, M., Fumagalli, S., Sanz, C., Herrero, C., Guerra, S., Fernandez, M., and Alemany, S. (2012) Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages. Mol. Biol. Cell 23, 2982-2992
39. Tsatsanis, C., Patriotis, C., Bear, S. E., and Tsichlis, P. N. (1998) The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. U.S.A. 95, 3827-3832
40. Das, S., Cho, J., Lambertz, I., Kelliher, M. A., Eliopoulos, A. G., Du, K., Tsichlis, P. N. (2005) Tpl2/cot signals activate ERK, JNK, and NF-κB in a cell-type and stimulus-specific manner. J. Biol. Chem. 280, 23748-23757
41. López-Peláez, M., Soria-Castro, I., Boscá, L., Fernández, M., and Alemany, S. (2011) Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: implications for NO synthase 2 expression. Eur. J. Immunol. 41, 1733-1741
42. Fleishaker, D. L., Garcia Meijide, J. A., Petrov, A., Kohen, M. D., Wang, X., Menon, S., Stock, T. C., Mebus, C. A., Goodrich, J. M., Mayer, H. B., and Zeiher, B. G. (2012) Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. Arthritis Res. Ther. 14, R11
43. Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E., Plachý, J., Brühl, H., Frink, M., Anders, H.-J., Vielhauer, V., Pfirstinger, J., Stangassinger, M., and Schlöndorff, D. (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704
44. Raborn, E. S., Marciano-Cabral, F., Buckley, N. E., Martin, B. R., and Cabral, G. A. (2008) The cannabinoid δ-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. J. Neuroimmune Pharmacol. 3, 117-129
45. Gao, J. L., Wynn, T. A., Chang, Y., Lee, E. J., Broxmeyer, H. E., Cooper, S., Tiffany, H. L., Westphal, H., Kwon-Chung, J., and Murphy, P. M. (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185, 1959-1968
46. Zhou, Y., Kurihara, T., Ryseck R.-P., Yang, Y., Ryan, C., Loy, J., Warr, G., and Bravo, R. (1998) Impaired macrophage function and enhanced T celldependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160, 4018-4025
47. Foti, M., Granucci, F., Aggujaro, D., Liboi, E., Luini, W., Minardi, S., Mantovani, A., Sozzani, S., and Ricciardi-Castagnoli, P. (1999) Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 11, 979-986
48. Weber, C., Weber, K. S., Klier, C., Gu, S., Wank, R., Horuk, R., and Nelson, P. J. (2001) Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO+ T cells. Blood 97, 1144-1146
49. Cao, C., Lawrence, D. A., Strickland, D. K., and Zhang, L. (2005) A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106, 3234-3241
50. Xu, L., Khandaker, M. H., Barlic, J., Ran, L., Borja, M. L., Madrenas, J., Rahimpour, R., Chen, K., Mitchell, G., Tan, C. M., DeVries, M., Feldman, R. D., and Kelvin, D. J. (2000) Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression. Eur. J. Immunol. 30, 227-235
51. Xu, L., Rahimpour, R., Ran, L., Kong, C., Biragyn, A., Andrews, J., Devries, M., Wang, J. M., and Kelvin, D. J. (1997) Regulation of CCR2 chemokine receptor mRNA stability. J. Leukocyte Biol. 62, 653-660
52. Kuipers, H. F., Biesta, P. J., Montagne, L. J., van Haastert, E. S., van der Valk, P., and van den Elsen, P. J. (2008)CCchemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. Blood 112, 1610-1619
53. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., and Lanzavecchia, A. (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769
54. Franchin, G., Zybarth, G., Dai, W. W., Dubrovsky, L., Reiling, N., Schmidtmayerova, H., Bukrinsky, M., and Sherry, B. (2000) Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164, 2592-2601
55. Verani, A., Scarlatti, G., Comar, M., Tresoldi, E., Polo, S., Giacca, M., Lusso, P., Siccardi, A. G, and Vercelli, D. (1997) C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185, 805-816
56. Lee, J., Mira-Arbibe, L., and Ulevitch, R. J. (2000) TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukocyte Biol. 68, 909-915
57. Kane, L. P., Mollenauer, M. N., Xu, Z., Turck, C. W., and Weiss, A. (2002) Akt-dependent phosphorylation specifically regulates Cot induction of NF-κB-dependent transcription. Mol. Cell. Biol. 22, 5962-5974
58. Robinson, M. J., Beinke, S., Kouroumalis, A., Tsichlis, P. N., and Ley, S. C. (2007) Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Mol. Cell. Biol. 27, 7355-7364
59. Amat, M., Benjamim, C. F., Williams, L. M., Prats, N., Terricabras, E., Beleta, J., Kunkel, S. L., and Godessart, N. (2006) Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo. Br. J. Pharmacol. 149, 666-675
60. Dairaghi, D. J., Oyajobi, B. O., Gupta, A., McCluskey, B., Miao, S., Powers, J. P., Seitz, L. C., Wang, Y., Zeng, Y., Zhang, P., Schall, T. J., and Jaen, J. C. (2012) CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood 120, 1449-1457
61. Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., and Luster, A. D. (2000) Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075-1080
62. Fife, B. T., Huffnagle, G. B., Kuziel, W. A., and Karpus, W. J. (2000) CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899-905
63. Dairaghi, D. J., Zhang, P., Wang, Y., Seitz, L. C., Johnson, D. A., Miao, S., Ertl, L. S., Zeng, Y., Powers, J. P., Pennell, A. M., Bekker, P., Schall, T. J., and Jaen, J. C. (2011) Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clin. Pharmacol. Ther. 89, 726-734